Advertisement

Program Development of Integrated Psychological Services for Hospitalized Patients with Intravenous Drug Use Histories

  • Andrew D. GillEmail author
  • Tara McCuin
  • Marlene Maron
Article

Abstract

Amid rising trends in opioid use, hospitalizations for health conditions secondary to intravenous drug use are becoming more common. Such patients often require prolonged hospitalizations and frequently present with substance use histories, co-occurring mental health diagnoses, and unique behavioral health needs. These issues can adversely impact completion of medical treatment and place added burden on hospital staff. There is a growing need for medical institutions to develop policies and procedures which address the specific emotional, behavioral, and substance use needs of this patient population. Because guidelines for doing so are sparse in the literature, this study outlines the University of Vermont Medical Center’s process of developing an in-hospital care agreement intended to (1) increase patient access to in-hospital need assessments, psychotherapy, and medication for opioid use disorders, (2) increase referrals for opioid use treatment beyond hospitalization, (3) standardize staff response to common challenging behaviors, and (4) provide staff with education and support for interacting with patients in effective ways. The multidisciplinary process of developing this care agreement, its specific details, lessons learned, and anticipated future directions are also discussed.

Keywords

Hospital Integrated Substance use Policy Program development 

Notes

Compliance with Ethical Standards

Conflict of interest

Andrew Gill, Tara McCuin, and Marlene Maron declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Supplementary material

10880_2019_9616_MOESM1_ESM.docx (19 kb)
Supplementary material 1 (DOCX 19 KB)

References

  1. Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., … Taubert, K. A. (2005). Infective endocarditis. Circulation, 111(23), e394–e434.Google Scholar
  2. Baler, R. D., & Volkow, N. D. (2006). Drug addiction: The neurobiology of disrupted self-control. Trends in Molecular Medicine, 12(12), 559–566.CrossRefGoogle Scholar
  3. Bellfield, H. (2012). Dual diagnosis policy (mental health and substance misuse). Retrieved from http://www.sompar.nhs.uk/media/1159/dual-diagnosis-policy-v1nov-2012.pdf.
  4. Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W., & Bigelow, G. E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54(1), 71–80.CrossRefGoogle Scholar
  5. Carroll, K. M., Ball, S. A., Nich, C., Martino, S., Frankforter, T. L., Farentinos, C., … Woody, G. E. (2006). Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence, 81(3), 301–312.CrossRefGoogle Scholar
  6. Chan, A. C., Palepu, A., Guh, D. P., Sun, H., Schechter, M. T., O’Shaughnessy, M. V., & Anis, A. H. (2004). HIV-positive injection drug users who leave the hospital against medical advice: The mitigating role of methadone and social support. Journal of Acquired Immune Deficiency Syndromes, 35(1), 56–59.CrossRefGoogle Scholar
  7. Chitwood, D. D., McBride, D. C., French, M. T., & Comerford, M. (1999). Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use & Misuse, 34(4–5), 727–746.CrossRefGoogle Scholar
  8. Cuomo, C., Sarchiapone, M., Giannantonio, M. D., Mancini, M., & Roy, A. (2008). Aggression, impulsivity, personality traits, and childhood trauma of prisoners with substance abuse and addiction. The American Journal of Drug and Alcohol Abuse, 34(3), 339–345.CrossRefGoogle Scholar
  9. Di Chiara, G., & North, R. A. (1992). Neurobiology of opiate abuse. Trends in Pharmacological Sciences, 13, 185–193.CrossRefGoogle Scholar
  10. Drainoni, M.-L., Farrell, C., Sorensen-Alawad, A., Palmisano, J. N., Chaisson, C., & Walley, A. Y. (2014). Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care and STDs, 28(2), 71–81.CrossRefGoogle Scholar
  11. Gladden, R. M., Martinez, P. & Seth, P. (2016). Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 states, 2013–2014. MMWR. Morbidity and Mortality Weekly Report.  https://doi.org/10.15585/mmwr.mm6533a2.Google Scholar
  12. Hasegawa, K., Espinola, J. A., Brown, D. F. M., & Camargo, C. A. (2014). Trends in U.S. emergency department visits for opioid overdose, 1993–2010. Pain Medicine (Malden, Mass.), 15(10), 1765–1770.CrossRefGoogle Scholar
  13. Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105(8), e55–e63.CrossRefGoogle Scholar
  14. Liebschutz, J. M., Crooks, D., Herman, D., Anderson, B., Tsui, J., Meshesha, L. Z., … Stein, M. (2014). Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial. JAMA Internal Medicine, 174(8), 1369–1376.CrossRefGoogle Scholar
  15. McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695.CrossRefGoogle Scholar
  16. Murdoch, D. R., Corey, G. R., Hoen, B., Miró, J. M., Fowler, V. G., Bayer, A. S., … Cabell, C. H. (2009). Clinical presentation, etiology and outcome of infective endocarditis in the 21st century: The international collaboration on endocarditis-prospective cohort study. Archives of Internal Medicine, 169(5), 463–473.CrossRefGoogle Scholar
  17. O’Toole, T. P., Pollini, R. A., Ford, D. E., & Bigelow, G. (2007). The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization. Medical Care, 45(11), 1110–1115.CrossRefGoogle Scholar
  18. Owens, P. L., Barrett, M. L., Weiss, A. J., Washington, R. E., & Kronick, R. (2014). Hospital inpatient utilization related to opioid overuse among adults, 1993–2012. Rockville, MD: Agency for Healthcare Research and Quality.Google Scholar
  19. Rollnick, S., Heather, N., & Bell, A. (1992). Negotiating behaviour change in medical settings: The development of brief motivational interviewing. Journal of Mental Health, 1(1), 25–37.CrossRefGoogle Scholar
  20. Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R.M. (2016). Increases in drug and opioid overdose deaths—United States, 2000–2014. American Journal of Transplantation, 16(4), 1323–1327.CrossRefGoogle Scholar
  21. Shanahan, C. W., Beers, D., Alford, D. P., Brigandi, E., & Samet, J. H. (2010). A transitional opioid program to engage hospitalized drug users. Journal of General Internal Medicine, 25(8), 803–808.CrossRefGoogle Scholar
  22. Sinha, R., Garcia, M., Paliwal, P., Kreek, M. J., & Rounsaville, B. J. (2006). Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Archives of General Psychiatry, 63(3), 324–331.CrossRefGoogle Scholar
  23. Squeglia, L. M., Jacobus, J., & Tapert, S. F. (2009). The influence of substance use on adolescent brain development. Clinical EEG and Neuroscience, 40(1), 31–38.CrossRefGoogle Scholar
  24. Stewart, A. L., Nápoles-Springer, A., Pérez-Stable, E. J., Posner, S. F., Bindman, A. B., Pinderhughes, H. L., & Washington, A. E. (1999). Interpersonal processes of care in diverse populations. The Milbank Quarterly, 77(3), 305–339.CrossRefGoogle Scholar
  25. Vermont Department of Health. (2017). Opioid misuse, abuse, & dependence in Vermont: data brief, April 2017. Retrieved from http://www.healthvermont.gov/sites/default/files/documents/2016/12/ADAP_Data_Brief_Opioid_Misuse_Abuse_Dependence.pdf.
  26. Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., & Lu, Y. (2001). Integrating primary medical care with addiction treatment: A randomized controlled trial. JAMA, 286(14), 1715–1723.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Psychological ServicesUniversity of Vermont Medical CenterBurlingtonUSA

Personalised recommendations